Literature DB >> 8543183

Cloning and sequence of a processed p53 pseudogene from rat: a potential source of false 'mutations' in PCR fragments of tumor DNA.

C M Weghorst1, G S Buzard, R J Calvert, J E Hulla, J M Rice.   

Abstract

We describe here the nucleotide (nt) sequence of a p53 processed pseudogene (psi-gene) from the normal F344 rat genome. Exon-derived primers were utilized to amplify and clone a 1447-bp polymerase chain reaction (PCR) product corresponding to the coding regions of exons 2-11 of the functional gene. This psi-gene is a cDNA-like sequence possessing 87% homology with the functional rat p53. We have also partially characterized two additional and distinctly different putative rat p53 psi-genes, focussing on the sequences surrounding the reported rat p53 mutational hot spots of codons 202R and 211R within exon 6/7. Each of these three psi-gene sequences contained various single- and/or double-nt substitutions, small deletions and insertions that distinguish them from p53. One substitution, 211R CGG-->CAG, found both in the cloned psi-gene and in one of the partially characterized, putative psi-genes, corresponded precisely with the sequence that has been reported as a mutation at one of the hot spots. Co-amplification of one or more of the p53 psi-genes with portions of the functional p53 is likely, if exon-based primers are utilized for PCR amplification of rat p53. Consequently, psi-gene sequences are potential sources of sequence variations that can be misidentified as somatic cell mutations by direct sequencing of inappropriately generated PCR products.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543183     DOI: 10.1016/0378-1119(95)00629-x

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Specific allelic loss of p16 (INK4A) tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis.

Authors:  Makoto Hiroyasu; Munetaka Ozeki; Haruyasu Kohda; Michiko Echizenya; Tomoyuki Tanaka; Hiroshi Hiai; Shinya Toyokuni
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

2.  Molecular characterization of p53 mutations in primary and secondary liver tumors: diagnostic and therapeutic perspectives.

Authors:  Apollonia Tullo; Elisabetta Sbisà
Journal:  Mol Biotechnol       Date:  2002-07       Impact factor: 2.695

3.  Genetic variation and phylogeography of central Asian and other house mice, including a major new mitochondrial lineage in Yemen.

Authors:  E M Prager; C Orrego; R D Sage
Journal:  Genetics       Date:  1998-10       Impact factor: 4.562

4.  Potential role of p53 mutation in chemical hepatocarcinogenesis of rats.

Authors:  Wei-Guo Deng; Yan Fu; Yu-Lin Li; Toshihiro Sugiyama
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

5.  p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation.

Authors:  K Honda; E Sbisà; A Tullo; P A Papeo; C Saccone; S Poole; M Pignatelli; R R Mitry; S Ding; A Isla; A Davies; N A Habib
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

6.  Hot-spot mutations in the p53 gene of liver nodules induced in rats fed DL-ethionine with a methyl-deficient diet.

Authors:  T Tsujiuchi; L Yeleswarapu; Y Konishi; B Lombardi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  TP53 copy number expansion is associated with the evolution of increased body size and an enhanced DNA damage response in elephants.

Authors:  Michael Sulak; Lindsey Fong; Katelyn Mika; Sravanthi Chigurupati; Lisa Yon; Nigel P Mongan; Richard D Emes; Vincent J Lynch
Journal:  Elife       Date:  2016-09-19       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.